Gene-silencing drug for rare hereditary disorder approved for NHS use

A therapy that uses RNA interference to treat the rare condition hereditary transthyretin-mediated amyloidosis has been approved for NHS use in England

Source:
https://www.newscientist.com/article/2209128-gene-silencing-drug-for-rare-hereditary-disorder-approved-for-nhs-use/?utm_campaign=RSS%7CNSNS&utm_source=NSNS&utm_medium=RSS&utm_content=home